In amyotrophic lateral sclerosis (ALS), disease-associated mutations are thought to alter the capacity of TDP-43 and FUS to participate in complexes mediated by phase separation, disrupting their normal function [84,85]. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.